Most lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in equivalent regions as classical opioid receptors, it binds to the big selection of endogenous opioids. Unlike most opioid receptors, thi